Loading...

FITC anti-mouse CD45 Antibody

Pricing & Availability
Clone
30-F11 (See other available formats)
Regulatory Status
RUO
Other Names
T200, Ly-5, LCA
Isotype
Rat IgG2b, κ
Ave. Rating
Submit a Review
Product Citations
publications
30-f11
C57BL/6 splenocytes stained with 30-F11 FITC
  • 30-f11
    C57BL/6 splenocytes stained with 30-F11 FITC
Compare all formats See FITC spectral data
Cat # Size Price Quantity Check Availability Save
103107 50 µg 29€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
103108 500 µg 84€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD45 is a 180-240 kD glycoprotein also known as the leukocyte common antigen (LCA), T200, or Ly-5. It is a member of the protein tyrosine phosphatase (PTP) family, expressed on all hematopoietic cells except mature erythrocytes and platelets. There are different isoforms of CD45 that arise from variable splicing of exons 4, 5, and 6, which encode A, B, and C determinants, respectively. CD45 plays a key role in TCR and BCR signal transduction. These isoforms are very specific to the activation and maturation state of the cell as well as cell type. The primary ligands for CD45 are galectin-1, CD2, CD3, CD4, TCR, CD22, and Thy-1.

Product Details
Technical data sheet

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Mouse thymus or spleen
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with FITC under optimal conditions.
Concentration
0.5 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.25 µg per 106 cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Blue Laser (488 nm)
Application Notes

Clone 30-F11 reacts with all isoforms and both CD45.1 and CD45.2 alloantigens of CD45.

Additional reported applications (for relevant formats) include: immunoprecipitation3, complement-dependent cytotoxicity1,5, immunohistochemistry (acetone-fixed frozen sections, zinc-fixed paraffin-embedded sections and formalin-fixed paraffin-embedded sections)4,6, Western blotting7, and spatial biology (IBEX)10,11. The Ultra-LEAF™ purified antibody (Endotoxin < 0.01 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for functional assays (Cat. No. 103163 and 103164).

Application References

(PubMed link indicates BioLegend citation)
  1. Podd BS, et al. 2006. J. Immunol. 176:6532. (FC, CMCD) PubMed
  2. Haynes NM, et al. 2007. J. Immunol. 179:5099. (FC)
  3. Ledbetter JA, et al. 1979. Immunol. Rev. 47:63. (IP)
  4. Simon DI, et al. 2000. J. Clin. Invest. 105:293. (IHC)
  5. Seaman WE. 1983. J. Immunol. 130:1713. (CMCD)
  6. Cornet A, et al. 2001. P. Natl. Acad. Sci. USA 98:13306. (IHC)
  7. Tsuboi S and Fukuda M. 1998. J. Biol. Chem. 273:30680. (WB) PubMed
  8. Liu F, et al. 2012. Blood. 119:3295. PubMed
  9. Pelletier AN, et al. 2012. J. Immunol. 188:5561. PubMed
  10. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  11. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. J Gautam, X Zhang, Y Yao 2016. Sci Rep. 6:36450. PubMed
  2. Li Y, et al. 2020. Nat Commun. 2.350694444. PubMed
  3. Gabitova-Cornell L, et al. 2020. Cancer Cell. 38(4):567-583.e11. PubMed
  4. Hanuscheck N, et al. 2022. J Exp Med. 219:. PubMed
  5. Klawitter M, et al. 2022. Int J Mol Sci. 23:. PubMed
  6. Zheng Y, et al. 2022. Proc Natl Acad Sci U S A. 119:e2121077119. PubMed
  7. Bowley TY, et al. 2022. Cancer Res Commun. 2:1436. PubMed
  8. Chen Y, et al. 2022. Am J Cancer Res. 12:5286. PubMed
  9. Zhang Y, et al. 2023. Invest Ophthalmol Vis Sci. 64:1. PubMed
  10. Sparbier CE, et al. 2023. Nat Cell Biol. 25:258. PubMed
  11. Li Y, et al. 2023. Adv Mater. 35:e2208923. PubMed
  12. Li M, et al. 2023. Front Immunol. 14:1087923. PubMed
  13. Chen H, et al. 2023. Nat Commun. 14:941. PubMed
  14. Ferriz M, et al. 2023. STAR Protoc. 4:102079. PubMed
  15. Volkova MV, et al. 2023. Int J Mol Sci. 24:. PubMed
  16. Solier S, et al. 2023. Int J Mol Sci. 24:. PubMed
  17. Li L, et al. 2023. iScience. 26:106095. PubMed
  18. Cheong LY, et al. 2023. Nat Commun. 14:1213. PubMed
  19. Xu H, et al. 2023. Acta Pharm Sin B. 13:678. PubMed
  20. Kozlovski S, et al. 2023. Front Immunol. 13:1041552. PubMed
  21. Rege SV, et al. 2023. Commun Biol. 6:292. PubMed
  22. Wang Y, et al. 2023. J Nanobiotechnology. 21:109. PubMed
  23. Zhang X, et al. 2023. Front Immunol. 14:1116749. PubMed
  24. Kim BH, et al. 2023. Sci Rep. 13:6577. PubMed
  25. Li T, et al. 2023. Nat Commun. 14:2498. PubMed
  26. Kase N, et al. 2023. Front Cell Dev Biol. 11:1022081. PubMed
  27. Huang T, et al. 2023. Cell Death Dis. 14:354. PubMed
  28. Guo X, et al. 2023. Mol Immunol. 160:32. PubMed
  29. Wang X, et al. 2023. Nature. 618:808. PubMed
  30. Akasaka H, et al. 2023. JCI Insight. 8:. PubMed
  31. Duquesne, P., Aoun, C., et al. 2025. Sci Adv. 11(42),eadx7672. PubMed
  32. Zhang, X., Ji, Z., et al. 2025. Mater Today Bio. 34(0),102166. PubMed
  33. Garo LP, et al. 2021. Nat Commun. 12:2419. PubMed
  34. Hutton C, et al. 2021. Cancer Cell. 39:1227. PubMed
  35. Nederlof R, et al. 2022. Front Immunol. 13:908023. PubMed
  36. Kataru RP, et al. 2021. Sci Signal. 14:. PubMed
  37. Sefik E, et al. 2022. Nature. 606:585. PubMed
  38. Leinroth AP, et al. 2022. Cell Rep. 39:110785. PubMed
  39. Doughty D, et al. 2022. Exp Biol Med (Maywood). 247:1433. PubMed
  40. Du M, et al. 2022. Cancer Sci. 113:2974. PubMed
  41. Grégoire C, et al. 2022. Immunity. 55:1216. PubMed
  42. Tao X, et al. 2022. EMBO J. 41:e110439. PubMed
  43. Blanco LP, et al. 2022. Arthritis Rheumatol. 74:1971. PubMed
  44. Li X, et al. 2022. Cell Mol Gastroenterol Hepatol. 14:1077. PubMed
  45. Hindy G, et al. 2022. J Clin Invest. 132: . PubMed
  46. Roy IM, et al. 2022. iScience. 25:105171. PubMed
  47. Mendivil-Perez M, et al. 2022. Med Oncol. 40:15. PubMed
  48. Chen X, et al. 2022. J Extracell Vesicles. 11:e12279. PubMed
  49. Zheng Z, et al. 2022. Cells. 11: . PubMed
  50. Voit RA, et al. 2023. Nat Immunol. 24:69. PubMed
  51. Varshney R, et al. 2023. iScience. 26:105750. PubMed
  52. Cheng P, et al. 2023. Pharmacol Res. 188:106643. PubMed
  53. Jin SM, et al. 2023. Nat Nanotechnol. :. PubMed
  54. Chen L, et al. 2023. Bioeng Transl Med. 8:e10377. PubMed
  55. Stravokefalou V, et al. 2023. Front Immunol. 13:1014802. PubMed
  56. Zhao Y, et al. 2023. Sci Adv. 9:eabo1360. PubMed
  57. Liu X, et al. 2022. Pain. 163:508. PubMed
  58. González H, et al. 2022. Cell. 185:729. PubMed
  59. Mecklenburg J, et al. 2022. Brain Behav Immun. 101:246. PubMed
  60. Na E, et al. 2022. Am J Physiol Lung Cell Mol Physiol. 322:L550. PubMed
  61. Ma Y, et al. 2022. Am J Physiol Heart Circ Physiol. 322:H622. PubMed
  62. Ajay AK, et al. 2022. Cell Rep. 38:110473. PubMed
  63. Mise Y, et al. 2022. Carcinogenesis. 43:647. PubMed
  64. Pfeifhofer-Obermair C, et al. 2022. Bio Protoc. 12:e4378. PubMed
  65. Li Z, et al. 2022. Nat Commun. 13:1845. PubMed
  66. Johnson DC, et al. 2018. Nat Med. 24:1151. PubMed
  67. Yu X, et al. 2020. Nat Commun. 11:1110. PubMed
  68. Xu X, et al. 2020. Chin Med. 15:33. PubMed
  69. Shakya S, et al. 2020. MethodsX. 7:101027. PubMed
  70. Hofmann I, et al. 2022. J Pharmacol Exp Ther. Online ahead of print. PubMed
  71. Hulsebus HJ, et al. 2022. Front Immunol. 13:884719. PubMed
  72. Li X, et al. 2022. Nat Commun. 13:2794. PubMed
  73. El-Hindi K, et al. 2022. Int J Mol Sci. 23:. PubMed
  74. Qi Z, et al. 2022. Nat Commun. 13:182. PubMed
  75. Ma J, et al. 2020. Adv Sci (Weinh). 7:2000609. PubMed
  76. Sharma GP, et al. 2021. PLoS One. 16:e0259042. PubMed
  77. Huang Z et al. 2017. Cell metabolism. 26(3):493-508 . PubMed
  78. McGill BE et al. 2018. The Journal of Neuroscience. 38(1):200-219 . PubMed
  79. Abdala-Valencia H, et al. 2014. Am J Physiol Lung Cell Mol Physiol. 307:482. PubMed
  80. Rodriguez-García A, et al. 2021. Nat Commun. 12:877. PubMed
  81. Tcheng M, et al. 2021. Blood. 137:3518. PubMed
  82. Prado C, et al. 2021. J Neuroinflammation. 18:292. PubMed
  83. Wang M, et al. 2022. Theranostics. 12:4513. PubMed
  84. Adachi Y, et al. 2022. Nat Commun. 13:5117. PubMed
  85. Bauer KM, et al. 2022. JCI Insight. 7:. PubMed
  86. Sepe JJ, et al. 2022. JACC Basic Transl Sci. 7:915. PubMed
  87. Zhu H, et al. 2018. Elife. 7:. PubMed
  88. Liu X, et al. 2020. Nature. . PubMed
  89. Liang W, et al. 2020. Nat Commun. 4.563888889. PubMed
  90. Pan D, et al. 2022. Cancer Res. 82:2748. PubMed
  91. Rao E, et al. 2021. Sci Immunol. 6:. PubMed
  92. Saito S, et al. 2020. Nutrients. 12:. PubMed
  93. Shao Y, et al. 2019. Diabetes. 68:2131. PubMed
  94. Lee AK, et al. 2020. Radiat Res. 193:305. PubMed
  95. Choi H et al. 2019. Cell Rep. 27(3):806-819 . PubMed
  96. Agelidis A, et al. 2019. Front Immunol. 10:500. PubMed
  97. Neumann AM et al. 2017. PloS one. 12(11):e0187330 . PubMed
  98. Zhao G, et al. 2020. Sci Adv. 6:00. PubMed
  99. Evren E, et al. 2020. Immunity. 54(2):259-275.e7. PubMed
  100. Wosczyna MN, et al. 2021. Cell Stem Cell. 28(7):1323-1334.e8. PubMed
  101. Pan H, et al. 2020. Mol Psychiatry. . PubMed
  102. Wang X, et al. 2021. Front Cell Dev Biol. 632805:9. PubMed
  103. Ihara S, et al. 2022. PLoS Negl Trop Dis. 16:e0010323. PubMed
  104. Talma N, et al. 2021. Aging Cell. 20:e13450. PubMed
  105. Zhang Q, et al. 2019. PLoS Biol. 17:e3000330. PubMed
  106. Tsuchiya N, et al. 2020. Cell Reports. 29(1):162-175.e9.. PubMed
  107. Ohigashi I, et al. 2020. Cell Reports. 29(9):2901-2916.e6.. PubMed
  108. Han C, et al. 2021. Cell Reports. 34(6):108706. PubMed
  109. Dai B, et al. 2022. Theranostics. 12:7603. PubMed
  110. Francian A, et al. 2021. J Drug Target. 29:754. PubMed
  111. Johansen AZ, et al. 2022. Pharmaceutics. 14:. PubMed
  112. Rolfes S, et al. 2020. Neurobiol Dis. 144:105024. PubMed
  113. Zhang Z, et al. 2021. Oncoimmunology. 10:1912472. PubMed
  114. Zhang C, et al. 2020. Cell Metabolism. 31(1):148-161.e5.. PubMed
  115. Lu Y, et al. 2020. Cell. 180(6):1081-1097. PubMed
  116. Meixiong J et al. 2019. Immunity. 50(5):1163-1171 . PubMed
  117. Xiao X, et al. 2019. Cell Discov. 5:2. PubMed
  118. Kucinski I, et al. 2020. EMBO J. :e104983. PubMed
  119. Müller A, et al. 2020. J Clin Invest. 5765:130. PubMed
  120. Liang Z, et al. 2020. Pain. 161:2089. PubMed
  121. Zhang W, et al. 2021. Cell Prolif. 54:e13058. PubMed
  122. Gui J, et al. 2020. Nat Cancer. 1:603. PubMed
  123. Hore ZL, et al. 2021. Wellcome Open Res. 6:68. PubMed
  124. Dane EL, et al. 2022. Nat Mater. 21:710. PubMed
  125. Yao L, et al. 2021. J Bone Miner Res. 36:1159. PubMed
  126. Koujah L, et al. 2021. Ocul Surf. 21:238. PubMed
  127. Kumari A, et al. 2022. Sci Rep. 12:15273. PubMed
  128. Li P, et al. 2021. Nat Immunol. 22:1107. PubMed
  129. Zhang X, et al. 2022. Cells. 11:. PubMed
  130. Emgård J, et al. 2018. Immunity. 143:419. PubMed
  131. Parada-Kusz M, et al. 2018. Dis Model Mech. 11:. PubMed
  132. Feng Y, et al. 2018. Kidney Dis (Basel). 4:95. PubMed
  133. Wosczyna MN et al. 2019. Cell Rep. 27(7):2029-2035 . PubMed
  134. Plein A, et al. 2018. Nature. 562:223. PubMed
  135. Kobayashi S, et al. 2019. J Immunol. 203:1447. PubMed
  136. Green DP, et al. 2019. Neuron. 101:412. PubMed
  137. Davidson S, et al. 2020. Cell Reports. 31(7):107628. PubMed
  138. Kusuyama J, et al. 2021. Cell Metabolism. 33(5):939-956.e8. PubMed
  139. Zein HS, et al. 2022. Sci Rep. 12:4834. PubMed
  140. Luo W, et al. 2022. Front Immunol. 13:816761. PubMed
  141. Deng Z, et al. 2017. Oncogene. 36:639. PubMed
  142. Barman PK, et al. 2019. J Immunol. 202:2720. PubMed
  143. Lim D, et al. 2018. Front Physiol. 9:47. PubMed
  144. Zhang K, et al. 2014. PLoS Pathog. 10:1004385. PubMed
  145. Mencarelli A, et al. 2016. Sci Rep. 6:30802. PubMed
  146. Lu X, et al. 2016. Nat Commun. 7: 12719. PubMed
  147. Hu J, et al. 2020. Theranostics. 7.154166667. PubMed
  148. Li J, et al. 2020. Elife. 9:00. PubMed
  149. Rosa JM, et al. 2021. British Journal of Pharmacology. . PubMed
  150. Derecka M, et al. 2020. Nat Immunol. 261:21. PubMed
  151. Morimoto A, et al. 2021. Nat Commun. 12:2136. PubMed
  152. Poillet-Perez L, et al. 2020. Nat Cancer. 1:923. PubMed
  153. Du Y, et al. 2022. Nat Commun. 13:231. PubMed
  154. Gañán-Gómez I, et al. 2022. Nat Med. . PubMed
  155. Chin AL, et al. 2021. Nat Commun. 12:5138. PubMed
  156. Srivastava S, et al. 2019. Cancer Cell. 35:489. PubMed
  157. Wang ECE, et al. 2019. Cell Stem Cell. 24:654. PubMed
  158. Cervera–Carrascon V, et al. 2020. Oncoimmunology. 9:1761229. PubMed
  159. Brigas HC, et al. 2021. Cell Reports. 36(9):109574. PubMed
  160. Zhu H, et al. 2021. Cell Metabolism. :. PubMed
  161. Nguyen PT, et al. 2020. Cell. 182(2):388-403.e15. PubMed
  162. Liu CY, et al. 2020. Cell Rep. 33:108275. PubMed
  163. Goldfarb Y, et al. 2021. J Exp Med. 218:. PubMed
  164. Zeng Q, et al. 2022. Front Immunol. 13:740805. PubMed
  165. Ye P, et al. 2022. Front Cardiovasc Med. 8:810477. PubMed
  166. Wan X, et al. 2018. Nature. 560:107. PubMed
  167. Al–Zaher AA, et al. 2018. Mol Ther Oncolytics. 0.376388889. PubMed
  168. Hepler C et al. 2018. eLife. 7 pii: e39636. PubMed
  169. Watanabe Y, et al. 2020. J Biol Chem. 295:17632. PubMed
  170. Engler AE, et al. 2020. Cell Reports. 33(13):108553. PubMed
  171. Ruan C, et al. 2020. Brain Behav Immun. 83:180. PubMed
  172. Sefik E, et al. 2021. Nat Biotechnol. . PubMed
  173. Cai Y, et al. 2019. Cell Rep. 27:3034. PubMed
  174. Crowell PD et al. 2019. Cell Rep. 28(6):1499-1510 . PubMed
  175. Maetzig T, et al. 2017. Mol Ther. 25:606. PubMed
  176. Burr ML, et al. 2019. Cancer Cell. 36:385. PubMed
  177. Wang F, et al. 2019. MAbs. 12:1685350. PubMed
  178. Ji DX, et al. 2019. Nat Microbiol. 1.644444444. PubMed
  179. Liu S, et al. 2020. Cell Host & Microbe. 26(6):779-794.e8.. PubMed
  180. Liang J, et al. 2020. Sci Adv. 6:eabc3646. PubMed
  181. Monaghan KL, et al. 2020. J Vis Exp. . PubMed
  182. Yamakawa D, et al. 2021. Cell Reports. 34(10):108817. PubMed
  183. Galle-Treger L, et al. 2016. Nat Commun. 7:13202. PubMed
  184. Milner MT, et al. 2022. STAR Protoc. 3:101295. PubMed
  185. Zhang X, et al. 2021. Proc Natl Acad Sci U S A. 118:. PubMed
  186. Xiao L, et al. 2021. Clin Cancer Res. 27:4338. PubMed
  187. Kotas ME, et al. 2022. JCI Insight. :. PubMed
  188. Rashid MH, et al. 2021. Oncol Rep. 45:1171. PubMed
  189. Jiang Y, et al. 2021. Cell Death Differ. 28:3009. PubMed
  190. Agelidis A, et al. 2021. JCI Insight. 6: . PubMed
  191. Coronel MM, et al. 2020. Sci Adv. 6:eaba5573. PubMed
  192. Pundir P, et al. 2020. Cell Host & Microbe. 26(1):114-122. PubMed
  193. Gastelum‐Aviña P et al. 2016. Journal of immunological methods. 438:42-50 . PubMed
  194. Zhou J, et al. 2019. Nat Commun. 10:2427. PubMed
  195. Yu X, et al. 2019. Nat Commun. 10:574. PubMed
  196. Su S et al. 2018. Cell. 175(2):442-457 . PubMed
  197. Ito K, et al. 2014. Proc Natl Acad Sci U S A. 111:3080. PubMed
  198. Saunders L, et al. 2015. Sci Transl Med. 7: 302ra136. PubMed
  199. Jiang Q, et al. 2020. JCI Insight. 5:00. PubMed
  200. Hasegawa T, et al. 2020. Sci Rep. 10:13480. PubMed
  201. Johnson DC, et al. 2020. Cell Death Dis. 0.894444444. PubMed
  202. Li CM, et al. 2020. Cell Reports. 33(13):108566. PubMed
  203. Zhang L, et al. 2021. iScience. 24(9):102942. PubMed
  204. Hu Y, et al. 2021. Cell Death Dis. 12:743. PubMed
  205. Minhas PS, et al. 2021. Nature. 590:122. PubMed
  206. Zhang X, et al. 2021. Mol Cancer Res. 19:1076. PubMed
  207. Liu S, et al. 2022. J Neuroinflammation. 19:35. PubMed
  208. Xiao Y, et al. 2022. Nat Commun. 13:758. PubMed
  209. Ali S, et al. 2021. PLoS One. 16:e0246646. PubMed
  210. Yang Z, et al. 2021. Nat Commun. 12:4852. PubMed
  211. Long JT, et al. 2022. Elife. 11:. PubMed
  212. Bravo-Caparrós I, et al. 2020. FASEB J. 34:5951. PubMed
  213. Zhang P, et al. 2022. Nat Commun. 13:1588. PubMed
  214. Sirvinskas D, et al. 2022. iScience. 25:104202. PubMed
  215. Wang Z et al. 2018. Immunity. 49(1):80-92 . PubMed
  216. Sarvi S et al. 2018. Cell chemical biology. 25(12):1456-1469 . PubMed
  217. Kim H, et al. 2020. Biomed Rep. 0.589583333. PubMed
  218. Li Z, et al. 2022. Nat Commun. 13:6321. PubMed
  219. Hou Y, et al. 2021. Sci Transl Med. 13:. PubMed
  220. Xu G, et al. 2022. Front Pharmacol. 13:896601. PubMed
  221. Zhou J, et al. 2022. Int J Oncol. 61: . PubMed
  222. Wang W, et al. 2021. J Am Heart Assoc. 10:e019142. PubMed
  223. Song J, et al. 2021. Am J Physiol Heart Circ Physiol. 320:H323. PubMed
  224. Zeis P, et al. 2020. Immunity. 53:775. PubMed
  225. Ben-Yehuda H, et al. 2021. Mol Neurodegener. 16:39. PubMed
  226. Qi F, et al. 2019. Front Microbiol. 2.140277778. PubMed
  227. Yu JM, et al. 2019. Nat Commun. 4.388888889. PubMed
  228. Zheng B, et al. 2021. Bioact Mater. 6:3879. PubMed
  229. Ferrer-Font L, et al. 2020. Elife. 9:. PubMed
  230. Sakai H, et al. 2022. iScience. 25:103928. PubMed
  231. Walker MT, et al. 2021. Front. Allergy. 2:. PubMed
  232. Kataru RP, et al. 2022. Front Aging. 3:864860. PubMed
  233. Pan Y, et al. 2021. Br J Pharmacol. 178:4907. PubMed
  234. Tomimatsu M, et al. 2022. Sci Rep. 12:16656. PubMed
  235. Ovadya Y, et al. 2018. Nat Commun. 9:5435. PubMed
  236. Okada R, et al. 2021. EBioMedicine. 67:103345. PubMed
  237. Hameed H, et al. 2022. Int J Mol Sci. 23:. PubMed
  238. Ding R, et al. 2022. J Neuroinflammation. 19:137. PubMed
  239. Liu R, et al. 2020. Eur J Vasc Endovasc Surg. 60:254. PubMed
  240. Fan ZP, et al. 2021. Front Immunol. 12:743354. PubMed
  241. Chen M, et al. 2019. Cell Stem Cell. 25:501. PubMed
  242. Sema Kurtulus et al. 2018. Immunity. 50(1):181-194 . PubMed
  243. Liu L et al. 2018. Cell stem cell. 23(4):544-556 . PubMed
  244. Zhao N, et al. 2018. J Clin Invest. 26:84. PubMed
  245. Cerina M, et al. 2017. Brain Behav Immun. 59:103-117. PubMed
  246. Simoes Eugénio M, et al. 2020. Cancers (Basel). 12:00. PubMed
  247. Chen L, et al. 2021. Theranostics. 11:6668. PubMed
  248. Sugita Y, et al. 2021. Oncol Rep. 45:. PubMed
  249. Banskota S, et al. 2021. Inflamm Bowel Dis. 27:914. PubMed
  250. Ruan Y, et al. 2022. Exp Ther Med. 23:47. PubMed
  251. Wang R, et al. 2022. J Immunother Cancer. 10:. PubMed
  252. Liao X, et al. 2022. JCI Insight. 7:. PubMed
  253. Kelley WJ, et al. 2022. JCI Insight. 7: . PubMed
  254. Ding L et al. 2018. Cell reports. 25(11):2972-2980 . PubMed
  255. Hao T, et al. 2019. Nat Commun. 10:3665. PubMed
  256. Zegarra‐Ruiz DF et al. 2018. Cell host & microbe. 25(1):113-127 . PubMed
  257. Chao Y, et al. 2020. Sci Adv. 6:eaaz4204. PubMed
  258. Kataru RP, et al. 2019. Cancer Immunol Res. 7:1345. PubMed
  259. Krivtsov AV, et al. 2020. Cancer Cell. 36(6):660-673.e11.. PubMed
  260. Hu X, et al. 2020. Neoplasia. 1.290972222. PubMed
  261. Sharma R, et al. 2021. J Neuroinflammation. 72:18. PubMed
  262. Watanabe Y, et al. 2020. J Biol Chem. . PubMed
  263. Sheng J, et al. 2021. eLife. 10:00. PubMed
  264. Zhou Y, et al. 2022. Theranostics. 12:5488. PubMed
  265. Sheng D, et al. 2022. J Immunother Cancer. 10:. PubMed
  266. El-Obeid A, et al. 2021. Exp Ther Med. 22:1081. PubMed
  267. Tr änkner D, et al. 2019. Cell Rep. 29:791. PubMed
  268. Lee C, et al. 2020. Front Immunol. 11:77. PubMed
  269. Eckert EC, et al. 2020. Mol Ther Oncolytics. 0.710416667. PubMed
  270. Poillet–Perez L, et al. 2018. Nature. 563:569. PubMed
  271. Padhye A, et al. 2019. Sci Rep. 9:4819. PubMed
  272. Li M, et al. 2020. Nat Commun. 4051:11. PubMed
  273. Spiljar M, et al. 2021. Cell Metab. 33:2231. PubMed
  274. Le TM et al. 2018. Journal of neurochemistry. 145(2):139-153 . PubMed
  275. Lee EKS, et al. 2018. Cell Host Microbe. 23:121. PubMed
  276. Shao Y, et al. 2019. Stem Cells. 37:1331. PubMed
  277. Krotova K, et al. 2019. Mol Ther Oncolytics. 15:166. PubMed
  278. Gupta R, et al. 2020. Cell Stem Cell. 26:527. PubMed
  279. Ichinose M, et al. 2021. Sci Rep. 7200:11. PubMed
  280. Zhang B, et al. 2021. Front Neurol. 607370:12. PubMed
  281. Dingler FA, et al. 2020. Mol Cell. . PubMed
  282. Wan Y, et al. 2020. Cell Rep. 33:108346. PubMed
  283. Badgujar DC, et al. 2020. PLoS Pathog. 16:e1009016. PubMed
  284. Li CY, et al. 2022. Int J Mol Sci. 23:. PubMed
  285. Wang H, et al. 2022. J Cancer. 13:2126. PubMed
  286. Zhang SJ, et al. 2021. Adv Sci (Weinh). 8:2003410. PubMed
  287. Zhang L, et al. 2021. Mol Ther. 29:744. PubMed
  288. Andreata F, et al. 2021. STAR Protoc. 2:100831. PubMed
  289. Ma Y, et al. 2020. Front Immunol. 11:586685. PubMed
  290. Pessoa Rodrigues C, et al. 2020. Sci Adv. 6:eaaz4815. PubMed
  291. Guarnerio J, et al. 2018. Nat Commun. 9:66. PubMed
  292. Wolf Y, et al. 2019. Cell. 179:219. PubMed
RRID
AB_312972 (BioLegend Cat. No. 103107)
AB_312973 (BioLegend Cat. No. 103108)

Antigen Details

Structure
Protein tyrosine phosphatase (PTP) family, 180-240 kD
Distribution

All hematopoietic cells except mature erythrocytes and platelets

Function
Phosphatase, T and B cell activation
Ligand/Receptor
Galectin-1, CD2, CD3, CD4, TCR, CD22, Thy-1
Cell Type
B cells, Dendritic cells, Mesenchymal Stem Cells, Tregs
Biology Area
Cell Biology, Immunology, Inhibitory Molecules, Innate Immunity, Neuroscience, Neuroscience Cell Markers, Stem Cells
Molecular Family
CD Molecules
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Trowbridge IS, et al. 1993. Annu. Rev. Immunol. 12:85.
3. Kishihara K, et al. 1993. Cell 74:143.
4. Pulido R, et al. 1988. J. Immunol. 140:3851.

Gene ID
19264 View all products for this Gene ID
UniProt
View information about CD45 on UniProt.org

Related FAQs

There are no FAQs for this product.

Other Formats

View All CD45 Reagents Request Custom Conjugation
Description Clone Applications
PE anti-mouse CD45 30-F11 FC
PE/Cyanine5 anti-mouse CD45 30-F11 FC
Purified anti-mouse CD45 30-F11 FC,IHC-F,CyTOF®,IP,CMCD,IHC,WB
PE/Cyanine7 anti-mouse CD45 30-F11 FC
PE/Dazzle™ 594 anti-mouse CD45 30-F11 FC
Brilliant Violet 711™ anti-mouse CD45 30-F11 FC
Brilliant Violet 785™ anti-mouse CD45 30-F11 FC
Brilliant Violet 650™ anti-mouse CD45 30-F11 FC
APC/Fire™ 750 anti-mouse CD45 30-F11 FC
Brilliant Violet 750™ anti-mouse CD45 30-F11 FC
TotalSeq™-A0096 anti-mouse CD45 30-F11 PG
Spark Blue™ 550 anti-mouse CD45 30-F11 FC
Spark NIR™ 685 anti-mouse CD45 30-F11 FC
TotalSeq™-B0096 anti-mouse CD45 30-F11 PG
Ultra-LEAF™ Purified anti-mouse CD45 30-F11 FC,CyTOF®,IP,CMCD,IHC,WB
TotalSeq™-C0096 anti-mouse CD45 30-F11 PG
Spark YG™ 570 anti-mouse CD45 30-F11 IHC-F
PE/Fire™ 640 anti-mouse CD45 30-F11 FC
APC/Fire™ 810 anti-mouse CD45 30-F11 FC
PE/Fire™ 700 anti-mouse CD45 30-F11 FC
APC anti-mouse CD45 30-F11 FC
Biotin anti-mouse CD45 30-F11 FC
FITC anti-mouse CD45 30-F11 FC
APC/Cyanine7 anti-mouse CD45 30-F11 FC
Alexa Fluor® 488 anti-mouse CD45 30-F11 FC,SB
Alexa Fluor® 647 anti-mouse CD45 30-F11 FC,ICC,IHC,3D IHC,SB
Pacific Blue™ anti-mouse CD45 30-F11 FC
Alexa Fluor® 700 anti-mouse CD45 30-F11 FC,SB
PerCP anti-mouse CD45 30-F11 FC
PerCP/Cyanine5.5 anti-mouse CD45 30-F11 FC
Alexa Fluor® 594 anti-mouse CD45 30-F11 IHC-F,FC,3D IHC
Brilliant Violet 421™ anti-mouse CD45 30-F11 FC,SB
Brilliant Violet 570™ anti-mouse CD45 30-F11 FC
Brilliant Violet 510™ anti-mouse CD45 30-F11 FC
Brilliant Violet 605™ anti-mouse CD45 30-F11 FC
Purified anti-mouse CD45 (Maxpar® Ready) 30-F11 FC,CyTOF®
Spark Violet™ 538 anti-mouse CD45 30-F11 FC
Spark YG™ 593 anti-mouse CD45 30-F11 FC
Spark Blue™ 574 anti-mouse CD45 Antibody 30-F11 FC
Spark Blue™ 515 anti-mouse CD45 30-F11 FC
Spark UV™ 387 anti-mouse CD45 30-F11 FC
PE/Fire™ 810 anti-mouse CD45 30-F11 FC
Spark PLUS UV395™ anti-mouse CD45 30-F11 FC
Spark Red™ 718 anti-mouse CD45 30-F11 FC
Spark PLUS V475™ anti-mouse CD45 Antibody 30-F11 FC
Spark YG™ 581 anti-mouse CD45 (Flexi-Fluor™) 30-F11 FC
StarBright UltraViolet 740 anti-mouse CD45 30-F11 FC
PE/Fire™ 744 anti-mouse CD45 30-F11 FC
StarBright UltraViolet 665 anti-mouse CD45 30-F11 FC
Go To Top Version: 2    Revision Date: 05.14.2013

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account